Variant report
Variant | esv2623459 |
---|---|
Chromosome Location | chr6:87836588-87839340 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RCN1P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111898745 | chr6:87836603-87836604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532106406 | chr6:87836658-87836659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547094497 | chr6:87836696-87836697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111312739 | chr6:87836703-87836704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs67760750 | chr6:87836704-87836705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs386407836 | chr6:87836707-87836708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs60889927 | chr6:87836710-87836711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201941502 | chr6:87836711-87836712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185084049 | chr6:87836716-87836717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71661288 | chr6:87836740-87836741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71014992 | chr6:87836760-87836761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140794902 | chr6:87836763-87836764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571517750 | chr6:87836766-87836767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187972363 | chr6:87836769-87836770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72418422 | chr6:87836771-87836772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71898175 | chr6:87836775-87836776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149801074 | chr6:87836777-87836778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576467235 | chr6:87836779-87836780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs55897946 | chr6:87836781-87836782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6937730 | chr6:87836782-87836783 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
21 | rs6917455 | chr6:87836807-87836808 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs548349651 | chr6:87836821-87836822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187832513 | chr6:87836822-87836823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78469754 | chr6:87836823-87836824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552012569 | chr6:87836824-87836825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113313286 | chr6:87836826-87836827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370372427 | chr6:87836846-87836847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538618123 | chr6:87836855-87836856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs59034165 | chr6:87836934-87836935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572483679 | chr6:87836979-87836980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192352292 | chr6:87837023-87837024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116467288 | chr6:87837064-87837065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150088219 | chr6:87837065-87837066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531191757 | chr6:87837070-87837071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200846615 | chr6:87837074-87837075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184640170 | chr6:87837091-87837092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558220978 | chr6:87837100-87837101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117434512 | chr6:87837115-87837116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145483728 | chr6:87837132-87837133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78075421 | chr6:87837133-87837134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9353452 | chr6:87837153-87837154 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs542360635 | chr6:87837179-87837180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559120040 | chr6:87837198-87837199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141217489 | chr6:87837200-87837201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs80092154 | chr6:87837209-87837210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113057225 | chr6:87837229-87837230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530584392 | chr6:87837246-87837247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368278108 | chr6:87837293-87837294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562150693 | chr6:87837304-87837305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs180823772 | chr6:87837338-87837339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:87836000-87837400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr6:87836800-87837200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr6:87837400-87840000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |